Dr. Montgomery joined the Hergenrother lab in August 2016 after receiving his Ph. D. in chemistry at the University of Texas. His graduate studies in the laboratory of Prof. Stephen Martin focused on the synthesis and evaluation of anticancer tetracyclic indole containing compounds.


As an Institute of Genomic Biology Post-Doctoral Fellow in the Anticancer Discovery from Pets to People (ADPP) Research Theme, Dr. Montgomery is working to elucidate and validate new targets for cancer therapies as well as advance current first-in-class therapeutics developed in the Hergenrother lab.

Please reload